Annals of Saudi Medicine
Publication of the King Faisal Specialist Hospital and Research Centre, Riyadh, Saudi Arabia
Users Online: 15 Home Print this page Email this page Small font sizeDefault font sizeIncrease font size
Home  About us   Issues     Search     Subscribe   Contact    Login 
 
ORIGINAL ARTICLE
Year : 2010  |  Volume : 30  |  Issue : 2  |  Page : 123-128

A meta-analysis of highly active anti-retroviral therapy for treatment of plasmablastic lymphoma


 Clinical School of Medical College of Nanjing University and Nanjing Jinling Hospital, Department of Pathology, Nanjing 210002, China

Correspondence Address:
Xiaojun Zhou
Department of Pathology, Nanjing Jinling Hospital, Nanjing 210002
China
Login to access the Email id
DOI: 10.4103/0256-4947.60517

PMID: 20220261



Get Permissions

Background and Objectives: Plasmablastic lymphoma is a recently described B-cell derived lymphoma. The prognosis of plasmablastic lymphoma patients is usually poor. We performed a systematic review of the literature on the use of highly active anti-retroviral therapy (HAART) and the prognosis of plasmablastic lymphoma. Methods : A comprehensive search of relevant databases, including Medline, Embase, the Cochrane Controlled Trials Register, the Cochrane Library, and the Science Citation Index yielded ten randomized controlled trials. Trials were divided into two groups according to therapy. The rates of plasmablastic lymphoma were analyzed using a fixed-effects model. Sensitivity analyses (on publication type, statistical model) were performed to further detect and evaluate clinically significant heterogeneity. Tests of survival for plasmablastic lymphoma were also performed by using Kaplan-Meier method. Results : Meta-analysis result showed that the prognosis of plasmablastic lymphoma patients was statistically different in the patients receiving HAART in addition to chemotherapy and/or radiotherapy than in the patients receiving the chemotherapy and/or radiotherapy alone (pooled relative risk=3.04; P=.03). Survival analyses also displayed a statistically significant difference (χ2 =6.22, P=.013). Conclusion : HAART in addition to chemotherapy and/or radiotherapy is effective in improving the prognosis of plasmablastic lymphoma. However, the small sample sizes increase the likelihood of bias in the studies in this meta-analysis, and therefore, the results should be taken cautiously.


[FULL TEXT] [PDF]*
Print this article     Email this article
 Next Article
 Previous Article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search Google Scholar for
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)
 

 Article Access Statistics
    Viewed261    
    Printed27    
    Emailed0    
    PDF Downloaded97    
    Comments [Add]    

Recommend this journal